摘要
目的探讨下调脐静脉内皮细胞(HUVEC)小窝蛋白1(Cav.1)表达对多发性骨髓瘤细胞硼替佐米敏感性的影响。方法构建靶向Cav-1基因的shRNA表达载体及阴性对照shRNA表达载体,转染HUVEC细胞株;以多发性骨髓瘤细胞系RPMl8226为对象,用MTT法检测不同浓度硼替佐米单独或联合50nmol/L地塞米松对单独培养及与HUVEC(转染干扰质粒或对照质粒)间接共培养的RPMl8226细胞增殖的抑制作用;用Western blot法检测Cav.1表达水平;用流式细胞术检测细胞周期、细胞凋亡率及活性氧(P.OS)水平变化。结果Cav.1shRNA.1转染的HuVEc(HuVEc。low)Cav-1蛋白表达水平与转染阴性对照载体组相比显著降低,其Cav-1蛋白相对表达水平为0.2199±0.0288对1.3195±0.2393(P〈0.01);RPMl8226细胞单独培养及与HUVEC、HUVEC共培养,硼替佐米作用的IC50值分别为20、50、65nmol/L。HUVEC、HUVEC可使RPMl8226细胞周期阻滞,RPMl8226细胞单独培养及与HUVEC、HUVEC共培养后RPMl8226细胞G0/G1期比例分别为28.5%、30.4%和36.2%;HUVEC保护RPMl8226细胞免于凋亡,20nmol/L硼替佐米作用于单独培养及与HUVEC、HUVEC共培养的RPMl8226细胞24h后,其细胞凋亡和(或)死亡率分别为66.8%、10.7%和8.6%;RPMl8226细胞可诱导HUVEC的氧化应激,共培养前后RPMl8226细胞ROS水平由15.0%上升至35.2%,HUVEC的ROS水平由80.4%上升至91.0%,HUVEC ROS水平由84.6%上升至96.8%。结论下调HUVECCav一1表达可促进共培养的RPMl8226细胞增殖,抑制细胞凋亡,使其阻滞在静息期,并降低RPMl8226对硼替佐米的敏感性。
Objective To investigate the sensitivity to bortezomib of RPMI8226 cells after co-cultured with down-regulated Caveolin (Cav) -1 expression of HUVECs by transfeetion with Cav-1 shRNA (HUVEC ). Methods Exposure to bortezomib with or without 50 nmol/L dexamethasone at different concentration, the proliferation of RPMI8226 was analyzed by MTT assay when it was cultured alone or co-cultured with HUVEC. Cav-1 expression was detected by using of Western blot and cell cycle, apoptosis and the level of reactive oxygen species (ROS) were analyzed by flow cytometry. Results Cav-1 expression was notably down-regulated in HUVECscav (0.2199±0.0288 vs 1.3195±0.2393 ) (P〈0.01). The IC50 of bortezomib for RPMI8226 cultured alone, co-cultured with HUVECs or HUVECC were 20 nmol/L, 50 nmol/L and 65 nmol/L, respectively. The percentages of G0-G1 phase in RPMI8226 cultured alone, co-cultured with HUVECs and HUVECscavow were 28.49%, 30.41%, and 36.15% respectively. The protection of RPMI 8226 against apoptosis by HUVECs was demonstrated that the apoptosis/death rates were 66.8%, 10.7% and 8.6% in RPMI8226 cultured alone, co-cultured with HUVECs and HUVECsc after exposure to 20 nmol/L bortezomib for 24 h. RPMI8226 could induce the oxidative stress of HUVECs before and after co-culture. The ROS level was raised from 15.0% to 35.2% in RPMI8226, from 80.4% to 91.0% in HUVECs, and from 84.6% to 96.8% in HUVECs. Conclusion The down-regulated Cav- I expression of HUVECs could promote proliferation and induce apoptosis of RMPI8226 cells, lead to G,JG, phase arrest, and reduce the sensitivity to bortezomib.
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2013年第11期946-951,共6页
Chinese Journal of Hematology
基金
国家自然科学基金(81071934、81272631)